What is Summus Global?
Headquartered in New York, Summus Global operates as a sophisticated virtual health advisory platform. The company bridges the gap between patients and top-tier medical specialists, providing a seamless interface for consultations that span the entire spectrum of health needs. By positioning itself as a critical decision-support tool, Summus Global addresses the inefficiencies inherent in traditional healthcare delivery. Its market position is characterized by a focus on high-touch, expert-led guidance, which has proven essential for enterprise clients seeking to improve health outcomes and reduce the burden of medical uncertainty for their populations.
How much funding has Summus Global raised?
Summus Global has raised a total of $111M across 6 funding rounds:
Series A
$21M
Series B
$21M
Other Financing Round
$22M
Other Financing Round
$19.5M
Private Equity
$7.5M
Private Equity
$20M
Series A (2021): $21M with participation from Outsiders Fund and Sator Grove Holdings
Series B (2021): $21M led by Savoy Capital, Outsiders Fund, Teamworthy Ventures, and Sator Grove Holdings
Other Financing Round (2022): $22M supported by Mitchell Rales and Glenstone
Other Financing Round (2023): $19.5M, investors not publicly disclosed
Private Equity (2025): $7.5M, investors not publicly disclosed
Private Equity (2026): $20M, investors not publicly disclosed
Key Investors in Summus Global
Savoy Capital
Savoy Capital is a New York-based financial services firm specializing in investment management and advisory services, providing tailored financial solutions to a diverse institutional and individual clientele.
Teamworthy Ventures
Teamworthy Ventures is a venture capital firm focused on software and software-enabled services, supporting long-term innovation across sectors including healthcare, education, and finance.
Glenstone
Glenstone is a transformative institution located near Washington, D.C., that integrates art, architecture, and nature, while also engaging in strategic investment activities.
What's next for Summus Global?
With the successful closure of this major enterprise-level funding, Summus Global is well-positioned to scale its operations and deepen its technological infrastructure. The strategic deployment of this capital will likely focus on expanding the breadth of its specialist network and enhancing the platform's analytical capabilities to provide more personalized health insights. As the company transitions into this next phase of maturity, it is expected to further integrate its services into broader enterprise health benefits packages, solidifying its role as an indispensable partner in the modern healthcare ecosystem. The focus remains on maintaining clinical excellence while scaling to meet the rising demand for accessible, expert-driven medical navigation.
See full Summus Global company page
